{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T16:22:07Z","timestamp":1772986927824,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hematological neoplasias are among the most common cancers worldwide, and the number of new cases has been on the rise since 1990, reaching 1 [...]<\/jats:p>","DOI":"10.3390\/ijms25126570","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:52:10Z","timestamp":1718355130000},"page":"6570","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-4802","authenticated-orcid":false,"given":"Ana Cristina","family":"Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR)\u2014Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2599-6433","authenticated-orcid":false,"given":"Raquel","family":"Alves","sequence":"additional","affiliation":[{"name":"Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR)\u2014Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4142-4841","authenticated-orcid":false,"given":"Ana Bela","family":"Sarmento-Ribeiro","sequence":"additional","affiliation":[{"name":"Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR)\u2014Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal"},{"name":"Hematology Service, Centro Hospitalar Universit\u00e1rio de Coimbra, Unidade Local de Sa\u00fade de Coimbra, 3000-061 Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global Burden of Hematologic Malignancies and Evolution Patterns over the Past 30 Years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","article-title":"Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371\u2013385), (S009286741830237X), (10.1016\/j.Cell.2018.02.060))","volume":"174","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"ref_4","first-page":"132","article-title":"Tumor Biomarkers for Diagnosis, Prognosis and Targeted Therapy. Signal Transduct","volume":"9","author":"Zhou","year":"2024","journal-title":"Target. Ther."},{"key":"ref_5","first-page":"00601","article-title":"Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care","volume":"OP23","author":"Tsimberidou","year":"2024","journal-title":"JCO Oncol. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bergantim, R., Peixoto da Silva, S., Pol\u00f3nia, B., Barbosa, M.A.G., Albergaria, A., Lima, J., Caires, H.R., Guimar\u00e3es, J.E., and Vasconcelos, M.H. (2022). Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients\u2014A Proof of Concept. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213686"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rocchi, S., Zannetti, B.A., Marconi, G., and Lanza, F. (2024). Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells, 13.","DOI":"10.3390\/cells13100853"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell, E.K., Borden, B.A., and Ghobrial, I.M. (2024). Early Detection of Precursor Diseases of Multiple Myeloma. Hematol. Oncol. Clin. N. Am., Online ahead of print.","DOI":"10.1016\/j.hoc.2024.03.003"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ohguchi, Y., and Ohguchi, H. (2023). DIS3: The Enigmatic Gene in Multiple Myeloma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044079"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Villa-Morales, M., P\u00e9rez-G\u00f3mez, L., P\u00e9rez-G\u00f3mez, E., L\u00f3pez-Nieva, P., Fern\u00e1ndez-Navarro, P., and Santos, J. (2023). Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210350"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in cancers: A double-edged sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3580719","DOI":"10.1155\/2020\/3580719","article-title":"NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis","volume":"2020","author":"Ju","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Namani, A., Matiur Rahaman, M., Chen, M., and Tang, X. (2018). Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer. BMC Cancer, 18.","DOI":"10.1186\/s12885-017-3907-z"},{"key":"ref_15","first-page":"1","article-title":"NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer","volume":"248\u2013249","author":"Wu","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jorge, J., Magalh\u00e3es, N., Alves, R., Lapa, B., Gon\u00e7alves, A.C., and Sarmento-Ribeiro, A.B. (2022). Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092207"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Aguilar-Garrido, P., Otero-Sobrino, \u00c1., Navarro-Aguadero, M.\u00c1., Velasco-Est\u00e9vez, M., and Gallardo, M. (2022). The Role of RNA-Binding Proteins in Hematological Malignancies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179552"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gallazzi, M., Ucciero, M.A.M., Faraci, D.G., Mahmoud, A.M., Al Essa, W., Gaidano, G., Mouhssine, S., and Cris\u00e0, E. (2022). New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147542"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Van Laethem, F., Donaty, L., Tchernonog, E., Lacheretz-Szablewski, V., Russello, J., Buthiau, D., Almeras, M., Moreaux, J., and Bret, C. (2022). LAIR1, an ITIM-Containing Receptor Involved in Immune Disorders and in Hematological Neoplasms. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416136"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Maher, N., Mouhssine, S., Matti, B.F., Alwan, A.F., and Gaidano, G. (2023). Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210374"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Al-Odat, O.S., Guirguis, D.A., Schmalbach, N.K., Yao, G., Budak-Alpdogan, T., Jonnalagadda, S.C., and Pandey, M.K. (2023). Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010644"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Louren\u00e7o, D., Lopes, R., Pestana, C., Queir\u00f3s, A.C., Jo\u00e3o, C., and Carneiro, E.A. (2022). Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine\u2014Are We There Yet?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112888"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Greilberger, J., Herwig, R., Kacar, M., Brajshori, N., Feigl, G., Stiegler, P., and Wintersteiger, R. (2022). Alpha-Ketoglutarate or 5-HMF: Single Compounds Effectively Eliminate Leukemia Cells via Caspase-3 Apoptosis and Antioxidative Pathways. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169034"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Jorge, J., Neves, J., Alves, R., Geraldes, C., Gon\u00e7alves, A.C., and Sarmento-Ribeiro, A.B. (2023). Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119167"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6570\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:58:46Z","timestamp":1760108326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25126570"],"URL":"https:\/\/doi.org\/10.3390\/ijms25126570","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}